Ascletis announces positive results from US phase Ia SAD study of small molecule oral GLP-1R agonist ASC30 in patients with obesity: Hong Kong, China Wednesday, January 22, 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback